Smith Brain Trust

What To Watch As Pharma Prices Take Center Stage

Pharmaceutical prices are poised to become a central issue for the next Congress, potentially forcing lawmakers to consider at least two factors that coincide with America’s higher-than-average drug prices.

Wednesday, November 14, 2018
What the Midterm Election Means for Stocks

The stock market was taking the election in stride, beginning a rally that could extend through next year. Maryland Smith's David Kass explains three reasons why.

Wednesday, November 7, 2018
Why Pot Businesses Are the New Wild West

Marijuana business entrepreneurs in states where pot use has been legalized are in for a serious trip. Maryland Smith's David P. Weber explains why.

Wednesday, November 7, 2018
Teaching Finance the Maryland Smith Way

Short-term thinking hurts companies. But finance students at Maryland Smith learn a different approach. They focus on value maximization, not profit maximization.

Wednesday, November 7, 2018
How Shareholder Primacy Wards Off Short-termism

Companies have built-in incentives to avoid short-termism. But they fall into the myopia trap when they confuse value creation with income maximization.

Friday, November 2, 2018
Here’s What’s Missing From the Shareholder Primacy Debate

Critics come down hard on shareholder primacy. But Maryland Smith professor Michael Faulkender says people err when they overlook risk/reward economics.

Friday, November 2, 2018
The Ignominy of Auto-Renewals

Companies often use automatic renewals, usually with ample warning to subscribers. But when they're sneaky about renewals, that crosses a line, a Maryland Smith expert says. 

Thursday, November 1, 2018
Is the NFL Becoming Too Political for Advertisers?

It’s left some brands doing a delicate balancing act, debating whether and how to advertise during an event that consistently draws more American viewers than any other TV broadcast.

Wednesday, October 31, 2018

Featured Videos

Do you choose to work with the most competent but least likeable person on the team? Or do you choose the most likeable but least competent person?

Buyers of luxury fashion can be passionate about the brands they shell out for. But can they be loyal when the brand becomes so popular that it loses its exclusivity?